BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8959850)

  • 1. Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation.
    Tamm M; Sharples L; Higenbottam T; Stewart S; Wallwork J
    Transpl Int; 1996; 9 Suppl 1():S299-302. PubMed ID: 8959850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
    Fisher AJ; Wardle J; Dark JH; Corris PA
    J Heart Lung Transplant; 2002 Nov; 21(11):1206-12. PubMed ID: 12431494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.
    Sharples LD; Tamm M; McNeil K; Higenbottam TW; Stewart S; Wallwork J
    Transplantation; 1996 Feb; 61(4):560-6. PubMed ID: 8610381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
    Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
    Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies.
    Tamm M; Sharples LD; Higenbottam TW; Stewart S; Wallwork J
    Am J Respir Crit Care Med; 1997 May; 155(5):1705-10. PubMed ID: 9154880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
    Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
    Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
    Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
    J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H; Girgis RE; Robbins RC; Conte JV; Nair RV; Valentine V; Berry GJ; Morris RE; Theodore J; Reitz BA
    Ann Thorac Surg; 1995 Dec; 60(6):1845-53. PubMed ID: 8787504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
    Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of obliterative bronchiolitis after heart-lung transplantation in children.
    Whitehead B; Rees P; Sorensen K; Bull C; Higenbottam TW; Wallwork J; Fabre J; Elliott M; de Leval M
    J Heart Lung Transplant; 1993; 12(6 Pt 1):903-8. PubMed ID: 8312313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchiolitis obliterans syndrome after heart-lung transplantation: a case report and review of literature.
    Sittpunt C; Wongtim S; Udompanich V; Kaewkittinarong K; Luengtaviboon K
    J Med Assoc Thai; 2004 Jun; 87(6):713-6. PubMed ID: 15279355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single lung transplantation for chronic obstructive pulmonary disease: pulmonary function and impact of bronchiolitis obliterans syndrome.
    Bjørtuft O; Geiran OR; Fjeld J; Skovlund E; Johansen B; Boe J
    Respir Med; 1996 Oct; 90(9):553-9. PubMed ID: 8984530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?
    Jackson CH; Sharples LD; McNeil K; Stewart S; Wallwork J
    J Heart Lung Transplant; 2002 Jun; 21(6):658-66. PubMed ID: 12057699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.